Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 60

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 1
Chunk 60
---
 to existing stockholders.

In the future, the Company is likely to issue additional shares of
common stock or issue preferred stock or incur debt. Debt and preferred stock will generally have priority upon liquidation. Such securities
also may be governed by an indenture or other instrument containing covenants restricting our operating flexibility. Additionally, any
convertible or exchangeable securities that the Company issues in the future may have rights, preferences and privileges more favorable
than those of the Company Common Stock. Because the decision to issue debt or equity in the future will depend on market conditions and
other factors beyond the Company’ control, we cannot predict or estimate the amount, timing, nature or success of our future capital
raising efforts. As a result, future capital raising efforts may reduce the market price of the Company Common Stock and warrants to purchase
the Company Common Stock and be dilutive to existing stockholders.

The Company granted registration rights to certain stockholders
and others and the future exercise of such rights may adversely affect the market price of our common stock.

Pursuant to an agreement entered into in connection with the issuance
and sale of the securities in the Company IPO, certain of the Company’s stockholders and their permitted transferees can demand
that the Company register the placement warrants, the placement rights, the shares of common stock issuable upon exercise of the placement
warrants, the shares of common stock included in the placement units, and the shares of common stock underlying the placement rights.
Additionally, holders of units that may be issued upon conversion of working capital loans can demand that the Company register the warrants
and rights included in such units, the shares of common stock issuable upon exercise of such warrants, the shares of common stock included
in such units, and the shares of common stock underlying such rights. The Company will bear the cost of registering these securities.
The registration and availability of such a significant number of securities for trading in the public market may have an adverse effect
on the market price of the Company Common Stock.

The abovementioned risks are specifically relevant to Company’s
recent Equity Line of Credit (“ELOC”) Agreement

In on February 25, 2025 we entered into an equity purchase agreement
and registration rights agreement (taken together, the “ELOC Agreement”) with White Lion GBM Innovation Fund, providing
that the Company has the right, but not the obligation, to require White Lion to purchase, from time to time, up to the lesser of (i)
$80,000,